Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 22 | 2024 | 2303 | 1.980 |
Why?
|
| Sexual Behavior | 4 | 2020 | 609 | 1.270 |
Why?
|
| Haiti | 12 | 2023 | 68 | 1.000 |
Why?
|
| Emigrants and Immigrants | 2 | 2016 | 137 | 0.950 |
Why?
|
| Risk-Taking | 7 | 2020 | 451 | 0.950 |
Why?
|
| Cardiomyopathies | 1 | 2023 | 56 | 0.830 |
Why?
|
| Substance-Related Disorders | 6 | 2016 | 730 | 0.800 |
Why?
|
| Heart Failure | 1 | 2023 | 235 | 0.690 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2016 | 22 | 0.540 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 519 | 0.530 |
Why?
|
| Pregnant Women | 1 | 2016 | 48 | 0.520 |
Why?
|
| Anti-HIV Agents | 4 | 2024 | 420 | 0.500 |
Why?
|
| Condoms | 1 | 2016 | 135 | 0.500 |
Why?
|
| Adult | 20 | 2024 | 11712 | 0.400 |
Why?
|
| Florida | 7 | 2024 | 410 | 0.380 |
Why?
|
| Risk Factors | 7 | 2020 | 3562 | 0.370 |
Why?
|
| Female | 19 | 2024 | 20969 | 0.360 |
Why?
|
| Humans | 28 | 2024 | 37093 | 0.350 |
Why?
|
| Depression | 1 | 2016 | 712 | 0.340 |
Why?
|
| Adolescent | 7 | 2021 | 5363 | 0.310 |
Why?
|
| Alcoholism | 3 | 2015 | 240 | 0.300 |
Why?
|
| Pregnancy | 3 | 2023 | 1549 | 0.300 |
Why?
|
| HIV Seropositivity | 1 | 2009 | 190 | 0.300 |
Why?
|
| Health Education | 3 | 2005 | 338 | 0.300 |
Why?
|
| Mentally Ill Persons | 1 | 2007 | 3 | 0.290 |
Why?
|
| United States | 5 | 2023 | 4223 | 0.290 |
Why?
|
| Stress, Psychological | 3 | 2016 | 583 | 0.290 |
Why?
|
| Cultural Competency | 2 | 2004 | 131 | 0.280 |
Why?
|
| Sex Offenses | 1 | 2007 | 37 | 0.280 |
Why?
|
| Urban Health | 1 | 2007 | 95 | 0.280 |
Why?
|
| Teaching Materials | 1 | 2005 | 8 | 0.260 |
Why?
|
| Translating | 1 | 2005 | 16 | 0.260 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2009 | 864 | 0.260 |
Why?
|
| Young Adult | 6 | 2021 | 4268 | 0.250 |
Why?
|
| Behavioral Research | 1 | 2005 | 39 | 0.250 |
Why?
|
| Health Services Research | 1 | 2005 | 148 | 0.240 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2015 | 73 | 0.240 |
Why?
|
| Sick Role | 1 | 2004 | 6 | 0.240 |
Why?
|
| Cultural Characteristics | 1 | 2004 | 125 | 0.220 |
Why?
|
| Logistic Models | 2 | 2016 | 923 | 0.220 |
Why?
|
| Adolescent Behavior | 3 | 2016 | 253 | 0.220 |
Why?
|
| Tuberculosis | 1 | 2023 | 63 | 0.210 |
Why?
|
| Transients and Migrants | 1 | 2020 | 39 | 0.180 |
Why?
|
| Minority Groups | 2 | 2004 | 596 | 0.170 |
Why?
|
| Health Status Disparities | 2 | 2004 | 642 | 0.170 |
Why?
|
| Anti-Retroviral Agents | 2 | 2021 | 147 | 0.160 |
Why?
|
| Interpersonal Relations | 1 | 2020 | 205 | 0.160 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2018 | 10 | 0.160 |
Why?
|
| Alcohols | 1 | 2018 | 12 | 0.160 |
Why?
|
| Mental Health | 2 | 2020 | 303 | 0.160 |
Why?
|
| Male | 12 | 2021 | 20025 | 0.150 |
Why?
|
| Residence Characteristics | 2 | 2017 | 322 | 0.140 |
Why?
|
| Sex Factors | 2 | 2017 | 898 | 0.140 |
Why?
|
| Negotiating | 1 | 2016 | 25 | 0.130 |
Why?
|
| Mass Screening | 2 | 2017 | 462 | 0.130 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2015 | 14 | 0.130 |
Why?
|
| Family Relations | 1 | 2016 | 46 | 0.130 |
Why?
|
| Safe Sex | 1 | 2016 | 76 | 0.130 |
Why?
|
| Postpartum Period | 1 | 2016 | 66 | 0.130 |
Why?
|
| Triage | 1 | 2015 | 26 | 0.130 |
Why?
|
| Middle Aged | 7 | 2016 | 10129 | 0.130 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2015 | 14 | 0.130 |
Why?
|
| Perception | 1 | 2016 | 195 | 0.130 |
Why?
|
| Child | 2 | 2016 | 3131 | 0.120 |
Why?
|
| Primary Prevention | 2 | 2005 | 59 | 0.120 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 664 | 0.120 |
Why?
|
| Cognition Disorders | 1 | 2015 | 233 | 0.110 |
Why?
|
| Pilot Projects | 2 | 2007 | 661 | 0.110 |
Why?
|
| Social Support | 1 | 2016 | 394 | 0.110 |
Why?
|
| Patient Dropouts | 1 | 2013 | 29 | 0.110 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 1067 | 0.110 |
Why?
|
| Educational Status | 3 | 2017 | 313 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1015 | 0.110 |
Why?
|
| Health Services Needs and Demand | 1 | 2013 | 146 | 0.100 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2013 | 221 | 0.100 |
Why?
|
| Health Services Accessibility | 3 | 2004 | 560 | 0.100 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 2721 | 0.100 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2017 | 189 | 0.090 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 2 | 2008 | 25 | 0.090 |
Why?
|
| Qualitative Research | 2 | 2021 | 446 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 767 | 0.090 |
Why?
|
| Patient Compliance | 2 | 2013 | 212 | 0.080 |
Why?
|
| Multilingualism | 2 | 2004 | 46 | 0.070 |
Why?
|
| Sickness Impact Profile | 1 | 2007 | 21 | 0.070 |
Why?
|
| Seroepidemiologic Studies | 1 | 2007 | 68 | 0.070 |
Why?
|
| Psychological Tests | 1 | 2007 | 53 | 0.070 |
Why?
|
| Schools, Public Health | 1 | 2005 | 8 | 0.070 |
Why?
|
| Healthcare Disparities | 3 | 2004 | 494 | 0.070 |
Why?
|
| Mental Health Services | 1 | 2007 | 118 | 0.060 |
Why?
|
| Genetic Association Studies | 2 | 2015 | 114 | 0.060 |
Why?
|
| Adolescent Health Services | 1 | 2004 | 29 | 0.060 |
Why?
|
| Developing Countries | 1 | 2004 | 99 | 0.060 |
Why?
|
| Preventive Health Services | 1 | 2004 | 64 | 0.060 |
Why?
|
| Polymorphism, Genetic | 2 | 2015 | 191 | 0.060 |
Why?
|
| Program Development | 1 | 2005 | 233 | 0.060 |
Why?
|
| Culture | 1 | 2005 | 173 | 0.060 |
Why?
|
| Medically Underserved Area | 1 | 2004 | 104 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 583 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2007 | 753 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2004 | 56 | 0.060 |
Why?
|
| Needs Assessment | 1 | 2004 | 170 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2020 | 1492 | 0.060 |
Why?
|
| Research Design | 1 | 2004 | 313 | 0.050 |
Why?
|
| Focus Groups | 1 | 2024 | 348 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 935 | 0.050 |
Why?
|
| Poverty | 1 | 2004 | 348 | 0.050 |
Why?
|
| Adaptation, Psychological | 1 | 2004 | 385 | 0.050 |
Why?
|
| RNA | 1 | 2023 | 241 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2015 | 628 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2003 | 215 | 0.050 |
Why?
|
| Dental Care | 1 | 2020 | 26 | 0.050 |
Why?
|
| Health Behavior | 1 | 2004 | 537 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2021 | 179 | 0.040 |
Why?
|
| Quality of Life | 1 | 2003 | 481 | 0.040 |
Why?
|
| Health Promotion | 1 | 2004 | 653 | 0.040 |
Why?
|
| Glutathione Synthase | 1 | 2018 | 1 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2018 | 3 | 0.040 |
Why?
|
| Blood Donors | 1 | 2018 | 17 | 0.040 |
Why?
|
| Arachidonic Acid | 1 | 2018 | 35 | 0.040 |
Why?
|
| World Health Organization | 1 | 2017 | 31 | 0.040 |
Why?
|
| Membrane Microdomains | 1 | 2018 | 47 | 0.040 |
Why?
|
| Glutathione Peroxidase | 1 | 2018 | 111 | 0.040 |
Why?
|
| HIV | 1 | 2018 | 98 | 0.040 |
Why?
|
| Cyclooxygenase 2 | 1 | 2018 | 104 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2018 | 155 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 431 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 441 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 601 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 461 | 0.030 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2008 | 164 | 0.030 |
Why?
|
| Time Factors | 1 | 2017 | 1742 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 515 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 885 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2018 | 938 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1130 | 0.030 |
Why?
|
| Syphilis | 1 | 2008 | 23 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2008 | 195 | 0.020 |
Why?
|
| Risk | 1 | 2008 | 267 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2008 | 253 | 0.020 |
Why?
|
| Psychometrics | 1 | 2008 | 318 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 610 | 0.020 |
Why?
|
| Comorbidity | 1 | 2008 | 623 | 0.020 |
Why?
|
| Saint Lucia | 1 | 2004 | 3 | 0.020 |
Why?
|
| Trinidad and Tobago | 1 | 2004 | 3 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2004 | 136 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2004 | 127 | 0.010 |
Why?
|
| Relaxation Therapy | 1 | 2003 | 4 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2004 | 339 | 0.010 |
Why?
|
| Health Surveys | 1 | 2004 | 373 | 0.010 |
Why?
|
| Fatigue | 1 | 2003 | 83 | 0.010 |
Why?
|
| Urban Population | 1 | 2004 | 333 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2004 | 294 | 0.010 |
Why?
|
| Attitude to Health | 1 | 2004 | 325 | 0.010 |
Why?
|
| Behavior Therapy | 1 | 2003 | 167 | 0.010 |
Why?
|
| Parents | 1 | 2004 | 329 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2003 | 215 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2004 | 309 | 0.010 |
Why?
|
| Health Status | 1 | 2003 | 380 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2003 | 1369 | 0.010 |
Why?
|
| Aged | 1 | 2003 | 6741 | 0.010 |
Why?
|